Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Rang in Aktien #33269
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Aktienkurs
$5.47
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$7.99M
Veränderung (1 Tag)
6.21%
Veränderung (1 Jahr)
7.47%
Land
US
Handel CNS Pharmaceuticals, Inc. (CNSP)

Kategorie

Preis CNSP mit Marktkapitalisierung von B
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
CNSP
$5.47
Marktkapitalisierung von CNS Pharmaceuticals, Inc.(CNSP)
Marktkapitalisierung: $7.99M
Mit Stand August 2026 hat CNS Pharmaceuticals, Inc. eine Marktkapitalisierung von $7.99M. Das macht CNS Pharmaceuticals, Inc. laut unseren Daten zum 33269th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von CNS Pharmaceuticals, Inc. von 2019 bis 2026
CNSP im Vergleich zu den Top 5 der beliebtesten stocks
Preis für CNSP Vermögenswert B Marktkapitalisierung von B Ergebnisse
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,730,311 $7.99M
$5.452T +68,195,709.39%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,072,189 $7.99M
$4.490T +56,164,241.21%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,848,028 $7.99M
$4.162T +52,066,224.70%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,515,450 $7.99M
$3.676T +45,986,185.89%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$1,938,442 $7.99M
$2.833T +35,437,596.65%